{'fraction_non_alphanumeric': 0.03668815071888944, 'fraction_numerical': 0.008924144769459593, 'mean_word_length': 5.594771241830065, 'pattern_counts': {'":': 0, '<': 2, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Delayed neutralization of interferon-&ggr; prevents lethality in primate Gram-negative bacteremic shock

Objective:Whether anticytokine therapies have a place in the treatment of severe sepsis and septic shock remains a question. Although a number of preclinical studies have shown efficacy in primate models of bacteremic shock when administered prophylactically, these same therapies have a significantly diminished effectiveness when administered therapeutically. This study investigated whether delayed administration of a novel anti-human interferon-&ggr; monoclonal antibody could improve outcome and reduce organ injury in a lethal model of Escherichia coli bacteremia, when administered after the onset of shock. Design:Randomized, prospective, double-blinded intervention study. Subjects:Cynomolgus monkeys. Interventions:Treatment with a humanized monoclonal antibody directed against human interferon-&ggr; (INNO 202), administered after the onset of shock, induced by the infusion of live E. coli. Measurements and Main Results:Five of the six vehicle-treated monkeys died or were killed within 24–72 hrs after E. coli administration, and all died within 5 days. In contrast, six of the eight animals treated with the anti-interferon-&ggr; survived for 7 days, and three of the eight animals survived 14 days (p = .013 vs. vehicle). Delayed treatment with the anti-interferon-&ggr; monoclonal antibody did not restore hemodynamics or reduce the amount of crystalloid-containing fluid required to resuscitate the animals but did attenuate renal failure (p < .05) and the magnitude of the inflammatory cytokine response (p < .05). Conclusions:In a primate model of E. coli bacteremic shock, delayed neutralization of interferon-&ggr; after the onset of shock improved survival and attenuated the pathologic changes associated with the development of organ dysfunction. These findings suggest that interferon-&ggr; blockade represents a potentially effective mode of late intervention in lethal septic shock.